ArticlePLOS global public health2025

End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study.

Vini Fardhdiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.